TP53 and small cell lung carcinoma: Antonia and Chiappori were the first to test the immunological and clinical effects of a cancer vaccine consisting of DCs transduced with an adenovirus expressing p53 (Ad.p53) in patients with extensive disease SCLC (69, 82).